<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xml:lang="EN" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Omega</journal-id><journal-id journal-id-type="iso-abbrev">ACS Omega</journal-id><journal-id journal-id-type="publisher-id">ao</journal-id><journal-id journal-id-type="coden">acsodf</journal-id><journal-title-group><journal-title>ACS Omega</journal-title></journal-title-group><issn pub-type="epub">2470-1343</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7808132</article-id><article-id pub-id-type="doi">10.1021/acsomega.0c05720</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title><italic>In Vivo</italic> Antinociceptive, Muscle Relaxant,
Sedative, and Molecular Docking Studies of Peshawaraquinone Isolated
from <italic>Fernandoa adenophylla</italic> (Wall. ex
G. Don) Steenis</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Alhumaydhi</surname><given-names>Fahad A.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Aljohani</surname><given-names>Abdullah S. M.</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Rashid</surname><given-names>Umer</given-names></name><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Shah</surname><given-names>Zafar Ali</given-names></name><xref rid="aff4" ref-type="aff">&#x02225;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath5"><name><surname>Rauf</surname><given-names>Abdur</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff5" ref-type="aff">&#x022a5;</xref></contrib><contrib contrib-type="author" id="ath6"><name><surname>Muhammad</surname><given-names>Naveed</given-names></name><xref rid="aff6" ref-type="aff">#</xref></contrib><contrib contrib-type="author" id="ath7"><name><surname>Al-Awthan</surname><given-names>Yahya S.</given-names></name><xref rid="aff7" ref-type="aff">&#x000b6;</xref><xref rid="aff8" ref-type="aff">&#x02207;</xref></contrib><contrib contrib-type="author" id="ath8"><name><surname>Bahattab</surname><given-names>Omar Salem</given-names></name><xref rid="aff7" ref-type="aff">&#x000b6;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Department
of Medical Laboratories, College of Applied Medical Sciences, <institution>Qassim University</institution>, Buraydah 51452, <country>Saudi Arabia</country></aff><aff id="aff2"><label>&#x02021;</label>Department
of Veterinary Medicine, College of Agriculture and Veterinary Medicine, <institution>Qassim University</institution>, Buraydah 51452, <country>Saudi
Arabia</country></aff><aff id="aff3"><label>&#x000a7;</label>Department
of Chemistry, <institution>COMSATS University Islamabad</institution>, Abbottabad Campus, Islamabad 22060, <country>Pakistan</country></aff><aff id="aff4"><label>&#x02225;</label>Department
of Agriculture Chemistry and Biochemistry, <institution>The University of Agriculture</institution>, Peshawar 25130, Khyber
Pakhtunkhwa, <country>Pakistan</country></aff><aff id="aff5"><label>&#x022a5;</label>Department
of Chemistry, <institution>University of Swabi</institution>, Anbar 23430, Khyber Pakhtunkhwa, <country>Pakistan</country></aff><aff id="aff6"><label>#</label>Department
of Pharmacy, <institution>Abdul Wali Khan University
Mardan</institution>, Mardan 23200, Khyber Pakhtunkhwa, <country>Pakistan</country></aff><aff id="aff7"><label>&#x000b6;</label>Department
of Biology, Faculty of Sciences, <institution>University
of Tabuk</institution>, Tabuk 71421, <country>Saudia Arabia</country></aff><aff id="aff8"><label>&#x02207;</label>Department
of Biology, Faculty of Science, <institution>Ibb University</institution>, Ibb 70270, <country>Yemen</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>mashaljcs@yahoo.com</email>, <email>abdurrauf@uoswabi.edu.pk</email>. Phone: <phone>923469488944</phone>.</corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>01</month><year>2021</year></pub-date><pub-date pub-type="collection"><day>12</day><month>01</month><year>2021</year></pub-date><volume>6</volume><issue>1</issue><fpage>996</fpage><lpage>1002</lpage><history><date date-type="received"><day>24</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>21</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2021 The
Authors. Published by American
Chemical Society</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>The Authors</copyright-holder><license><license-p>This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05720_0006" id="ab-tgr1"/></p><p><italic>Fernandoa
adenophylla</italic> (Wall. ex
G. Don) Steenis is traditionally used to cure various diseases and
can be included as an ingredient in massage oils, which are supposed
to comfort muscular tension and pain. This study was designed to assess
the antinociceptive, muscle relaxant, and molecular docking properties
of a novel compound, namely, (5a<italic>R</italic>,5a1<italic>R</italic>,6<italic>R</italic>,7a<italic>S</italic>,14b<italic>R</italic>,15<italic>R</italic>)15-hydroxy-7a-methyl-6-(2-methylprop-1-en-1-yl)-7,7a,14b,15-tetrahydro-5<italic>H</italic>-t-5a,15methanobenzo[g]benzo[5,6]azuleno[1,8-<italic>bc</italic>]chromene-5,9,14,16(5a1<italic>H</italic>,6<italic>H</italic>)- tetraone
(peshawaraquinone), isolated from the methanolic extract of <italic>F. adenophylla</italic> in an animal model. The chemical structure
of the isolated compound was elucidated using advanced spectroscopic
techniques and further confirmed by XRD analysis. Compound <bold>1</bold> was tested against hot plate-induced noxious stimuli at various
doses (2.5, 5, 10, and 15 mg/kg i.p.). The muscle relaxation potency
of compound <bold>1</bold> was evaluated in the inclined and traction
test, while the open-field test was used for the determination of
sedative potential. The isolated compound was also subjected to acute
toxicity analysis. The compound was then subjected to molecular docking
analysis to determine the exact mechanism of action. Compound <bold>1</bold> demonstrated significant (<italic>p</italic> &#x0003c; 0.05)
analgesic effect in a dose-dependent manner. A noticeable muscle relaxant
effect was observed with the passage of time in both experimental
models. The compound <bold>1</bold> showed a significant (<italic>p</italic> &#x0003c; 0.05) sedative effect, and in an acute toxicity study,
the compound <bold>1</bold> was devoid of any noxious effects. The
docking studies showed preferential affinity for &#x003bc;-opioid and
GABAA receptors. Hence, the prospective antinociceptive and muscle
relaxant and sedative properties are probably mediated through these
two target interactions.</p></abstract><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>ao0c05720</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>ao0c05720</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p>Medicinal plants are the main source of active phytochemicals that
can be utilized for the production of modern medicines.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Natural product-derived drugs and phytomedicine
are becoming popular compared to synthetic drugs because of their
low cost and fewer side effects. Synthetic drugs not only have adverse
side effects and are more costly but also promote bacterial pathogen
resistance.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> The discovery of crude drugs
from medicinal plants is dynamic; therefore, ethnomedicinal studies
play a key role in their development.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> The
folkloric usage of medicinal plants plays an important role in the
development of the majority of drugs.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> In
this regard, biological and phytochemical screening as well as pharmacological
screening assisted the drug industry.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> Phytochemicals
such as 8-hydroxyisodiospyrin, diospyrin, and pistagremic acid isolated
from various plant species have been reported for analgesic, anti-inflammatory,
and antimicrobial activities.<sup><xref ref-type="bibr" rid="ref6">6</xref>&#x02212;<xref ref-type="bibr" rid="ref8">8</xref></sup></p><p>Several plant species with
medicinal importance have already been
explored; however, there are many unexplored higher plant species.
In the search of such species, the present study was conducted, where <italic>Fernandoa adenophylla</italic> was explored scientifically. <italic>F. adenophylla</italic> is a member of the family <italic>Bignoniacea</italic>, which is dispersed in Africa and Southeast
Asia.<sup><xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref></sup> This species is also known as Ziron, Dhopa-phali,
Mostanphul, Karen wood, and Lotum-poh.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup><italic>F. adenophylla</italic> has been used in the
folkloric system for the treatment of constipation (Bangladesh), haemorrhoids
(Bangladesh), and snake bites (India) as well as skin disorders in
Thailand.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> Traditionally, this plant is
used by local people for the treatment of premature ejaculation, nocturnal
emission, diabetes, amenorrhoea, microbial infections, sepsis, and
other skin diseases.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> The different extracts
of <italic>F. adenophylla</italic> have been documented
to have various pharmacological effects, including antihypertensive,
leishmanicidal antifungal, antibacterial, and anti-TB properties.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> Plants contain different phytochemicals, such
as &#x003b2;-amyrin, lapachol, &#x003b1;-lapchone adenophylone, dehydro-&#x003b1;-lapchone,
dehydro-iso-&#x003b1;-lapchone, dilapachone, tecomoquinone-I, and &#x003b2;-sitosterol.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> All species of <italic>Bignoniacea</italic> contain lapachol in relatively large amounts. Lapachol and its derivatives
have been reported to have a wide variety of biological activities,
including anti-inflammatory, antimalarial, antiendemic, antiulcer,
anticarcinogenic, antiabscess, viricidal, and termiticical activities.<sup><xref ref-type="bibr" rid="ref13">13</xref>&#x02212;<xref ref-type="bibr" rid="ref15">15</xref></sup> The chemical constituents including peshawaraquinone, indanone derivatives,
lapachol, and &#x003b1;-lapachol have been documented for phosphodiesterase
1 and anti-inflammatory properties. Based on medicinal importance,
this study was designed to investigate the antinociceptive effects,
muscle coordination, and molecular docking of peshawaraquinone isolated
from <italic>F. adenophylla.</italic></p></sec><sec id="sec2"><label>2</label><title>Materials and Methods</title><sec id="sec2.1"><label>2.1</label><title>Plant Material Collection</title><p>The root heartwood of <italic>F. adenophylla</italic> was obtained from various regions of the University of Peshawar,
Khyber Pakhtunkhwa, Pakistan, in December 2012. The identification
of plant specimens was performed by Dr. Muhammad Ilyas University
of Swabi KP, Pakistan. The voucher specimen number UOS/Bot761 was
kept at the Herbarium University of Swabi, KP, Pakistan.</p></sec><sec id="sec2.2"><label>2.2</label><title>Extraction, Fractionation,
and Isolation</title><p>The collected root heartwood (5 kg) of <italic>F. adenophylla</italic> was kept in the shade until dried.
The dried plant sample was ground and then subjected to cold extraction
with methanol (20 L) for 2 weeks. The obtained methanolic extract
(112.89 g) was subjected to successive fractionation using polar and
nonpolar organic solvents in the order of increasing polarity as per
standard procedures.<sup><xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref17">17</xref></sup> Upon fractionation and then successive
concentration on a rotary evaporator, different fractions, including
hexane (9.76 g), chloroform (27.32 g), ethyl acetate (21.11 g), and
methanolic fractions (25.98 g), were obtained. Based on comparative
TLC, the methanolic fraction (25.98 g) was subjected to silica gel
chromatographic analysis using chloroform and methanol in various
proportions, which afforded 114 fractions. These collected subfractions
were compiled through TLC, which yielded seven subfractions. The subfractions
were subjected to a normal-phase, repeated chromatographic technique
using chloroform and methanol as a solvent system (7:3), which yielded
crystalline compound <bold>1</bold> (90 mg; 99.87% pure). The purity
of compound <bold>1</bold> was confirmed by TLC. The chemical structure
of compound <bold>1</bold> (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>) was identified by comparing the spectroscopic data
with those of previously reported compounds.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup></p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Chemical
structure (a) and XRD image (b) of peshawaraquinone (<bold>1</bold>) isolated from the methanolic fraction of <italic>F. adenophylla</italic>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05720_0002" id="gr1" position="float"/></fig></sec><sec id="sec2.3"><label>2.3</label><title>Animals</title><p>BALB/c mice
of both sexes having weight 18&#x02013;22 g (21 weeks old) were used
for <italic>in vivo</italic> pharmacological evaluations as per standard
methods.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> Animals were fed standard laboratory
food and water <italic>ad libitum</italic>. Before the experimental
procedure, animals were acclimated under laboratory conditions (12/12
h dark and light and a temperature of 25 &#x000b0;C). All animals were
examined physically for any health issues, and only healthy, that
is, physically active, mice were included in the study. All the experimental
procedures were presented and thoroughly approved by the ethical committee
of the Department of Pharmacy UOS (Phrm323) University of Swabi KPK,
Pakistan. The same animals were used throughout experimental procedures
including acute toxicities.</p></sec><sec id="sec2.4"><label>2.4</label><title>Antinociceptive Activity</title><p>The hot-plate test was used for the evaluation of the tested compound
following our published protocol.<sup><xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref20">20</xref></sup> Animals were
categorized into different groups (<italic>n</italic> = 6), that is,
the positive control, negative control, and test groups. A pretest
was performed for the experimental animals on a hot plate (Harvard
apparatus) maintained at 55 &#x000b1; 1 &#x000b0;C. All animals that demonstrated
a latency time greater than 15 s were excluded from the study. The
positive group was treated with tramadol (10 mg/kg, i.p.), and the
negative control group was injected with normal saline (10 mL/kg,
i.p.). The tested groups (four) were administered peshawaraquinone
1 (2.5, 5, 10, and 15 mg/kg, PO). Thirty minutes after the abovementioned
administration, the animals were placed on the hot plate maintained
at 55 &#x000b1; 1 &#x000b0;C, and the latency time (time for which the mouse
remained on the hot plate (55 &#x000b1; 0.1 &#x000b0;C) without licking
or flicking of the hind limb or jumping) was recorded in seconds.
To prevent tissue harm, a cut-off time of 30 s was used for each animal.
The latency time was noted for all groups at regular intervals, that
is, after 30, 60, 90, and 120 min.</p></sec><sec id="sec2.5"><label>2.5</label><title>Muscle
Relaxant Activity</title><p>The muscle coordination effect of peshawaraquinone <bold>1</bold> (2.5, 5, 10, and 15 mg/kg, PO) was evaluated through traction
tests
and inclined plane tests using specific wires for hanging and special
wood inclined planes, respectively. The activity was performed exactly
following our published procedures.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> Animals
were classified into positive control (diazepam 0.5 mg/kg, IP), negative
control (normal saline 10 mL/kg, ip), and test groups (<italic>n</italic> = 6). Thirty minutes after these administrations, each animal was
tested for muscle relaxant effects in both models. In the case of
the traction experimental model, each animal was allowed to hang by
a wire on their hind leg, and the duration of holding the wire by
claws was noted in seconds. Hanging for less than 5 s means the muscle
relaxant potential and vice versa. Regarding the inclined plane 30
min after administration, animals were allowed to slide on the inclined
plane. Resistance to sliding was considered for no muscle coordination,
and ease of sliding was considered for an animal with relaxed muscles.</p></sec><sec id="sec2.6"><label>2.6</label><title>Open-Field Test</title><p>This experimental system
was used for the evaluation of sedative
potential. Animals were classified as described above. The apparatus
used for this activity comprised an area of white wood (150 cm diameter)
surrounded by stainless-steel walls and was divided into 19 squares
by black lines. The open-field apparatus was placed inside a light-
and sound-attenuated room.<sup><xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref21">21</xref></sup> Thirty minutes after
treatment, each animal was allowed to move from the center of the
box. The maximum number lines crossed by the animal were considered
no sedation. Animal was considered to be sedated with hindered movement.
The number of lines crossed by each animal was used to find sedative
effects in statistical calculations. The doses of diazepam, normal
saline, and compound <bold>1</bold> were the same as in previous experiments.</p></sec><sec id="sec2.7"><label>2.7</label><title>Acute Toxicity</title><p>Peshawaraquinone
1 was evaluated for acute toxicity effects, and animals were classified
into a saline-treated group (<italic>n</italic> = 6) and peshawaraquinone <bold>1</bold>-treated group. Peshawaraquinone 1 was administered at doses
of 10, 25, 50, 100, and 200 mg/kg (P.O). After 30 min of these treatments,
each animal was monitored carefully for any gross effect for 8 h.
The mortality rate was observed for 24 h.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup></p></sec><sec id="sec2.8"><label>2.8</label><title>Statistical Analysis</title><p>The results obtained
from biological studies are displayed as the
mean &#x000b1; standard deviation to identify the level of significant
difference (<italic>p</italic> &#x0003c; 0.05 or 0.01) for each group of
experimental mice. One-way analysis of variance (ANOVA) was performed
by Dunnett&#x02019;s multiple comparison test.</p></sec><sec id="sec2.9"><label>2.9</label><title>Docking
Studies</title><p>The docking experiments were performed using the
molecular operating
environment (MOE) docking program version 2016.08.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> The three-dimensional (3D) structures of the enzymes with
their cocrystallized ligands were downloaded from the Protein Data
Bank. The 3D crystal structure of the &#x003bc;-opioid receptor has
a native ligand (PDB id = 5C1M). The GABAnergic homopentamer from humans was obtained
from the Protein Data Bank (PDB id = 4COF). The docking algorithm was authenticated
by the redocking of native ligands. The computed root mean square
deviation (rmsd) between the experimental and redocked poses was found
within the threshold limit (&#x0003c;2 &#x000c5;). The 3D structure of the
compound was built in an MOE using a builder module. Energy minimization
of the ligand, preparation of structures of the downloaded enzymes,
and active site identification were carried out according to a previously
reported procedure.<sup><xref ref-type="bibr" rid="ref24">24</xref>&#x02212;<xref ref-type="bibr" rid="ref26">26</xref></sup> The assessment of the docking results and investigation
of their surface with graphical representations were carried out using
MOE and a discovery studio visualizer.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup></p></sec></sec><sec id="sec3"><label>3</label><title>Results</title><sec id="sec3.1"><label>3.1</label><title>Antinociceptive Effect</title><p>The compound <bold>1</bold> demonstrated a dose- and duration-dependent
central antinociceptive effect, as demonstrated in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>. Peshawaraquinone <bold>1</bold> significantly increased the pain threshold level and mitigated pain
sensation in mice. This effect was seen in the first 30 min postadministration
and remained significant (<italic>p</italic> &#x0003c; 0.001) for 120 min
of the experimental duration.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Antinociceptive
Effect of Compound <bold>1</bold> Isolated from <italic>F.
adenophylla</italic><xref rid="t1fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="char" char="&#x000b1;"/><col align="char" char="&#x000b1;"/><col align="char" char="&#x000b1;"/><col align="char" char="&#x000b1;"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th style="border:none;" align="center">&#x000a0;</th><th colspan="4" align="center" char="&#x000b1;">time
(minutes)<hr/></th></tr><tr><th style="border:none;" align="center">group</th><th style="border:none;" align="center">dose mg/kg</th><th style="border:none;" align="center" char="&#x000b1;">30</th><th style="border:none;" align="center" char="&#x000b1;">60</th><th style="border:none;" align="center" char="&#x000b1;">90</th><th style="border:none;" align="center" char="&#x000b1;">120</th></tr></thead><tbody><tr><td style="border:none;" align="left">normal saline</td><td style="border:none;" align="left">10&#x000a0;mL</td><td style="border:none;" align="char" char="&#x000b1;">9.20&#x000a0;&#x000b1;&#x000a0;0.08</td><td style="border:none;" align="char" char="&#x000b1;">9.20&#x000a0;&#x000b1;&#x000a0;0.09</td><td style="border:none;" align="char" char="&#x000b1;">9.21&#x000a0;&#x000b1;&#x000a0;0.07</td><td style="border:none;" align="char" char="&#x000b1;">9.18&#x000a0;&#x000b1;&#x000a0;0.12</td></tr><tr><td style="border:none;" align="left">tramadol</td><td style="border:none;" align="left">10</td><td style="border:none;" align="char" char="&#x000b1;">24.34&#x000a0;&#x000b1;&#x000a0;0.08**</td><td style="border:none;" align="char" char="&#x000b1;">26.09&#x000a0;&#x000b1;&#x000a0;0.100***</td><td style="border:none;" align="char" char="&#x000b1;">25.76&#x000a0;&#x000b1;&#x000a0;0.12***</td><td style="border:none;" align="char" char="&#x000b1;">25.68&#x000a0;&#x000b1;&#x000a0;0.44***</td></tr><tr><td style="border:none;" align="left">peshawaraquinone</td><td style="border:none;" align="left">2.5</td><td style="border:none;" align="char" char="&#x000b1;">13.80&#x000a0;&#x000b1;&#x000a0;0.52*</td><td style="border:none;" align="char" char="&#x000b1;">14.84&#x000a0;&#x000b1;&#x000a0;0.88*</td><td style="border:none;" align="char" char="&#x000b1;">14.83&#x000a0;&#x000b1;&#x000a0;0.65*</td><td style="border:none;" align="char" char="&#x000b1;">14.66&#x000a0;&#x000b1;&#x000a0;1.65*</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">5</td><td style="border:none;" align="char" char="&#x000b1;">15.70&#x000a0;&#x000b1;&#x000a0;0.89**</td><td style="border:none;" align="char" char="&#x000b1;">18.65&#x000a0;&#x000b1;&#x000a0;0.93**</td><td style="border:none;" align="char" char="&#x000b1;">18.98&#x000a0;&#x000b1;&#x000a0;0.92**</td><td style="border:none;" align="char" char="&#x000b1;">17.67&#x000a0;&#x000b1;&#x000a0;1.17**</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">10</td><td style="border:none;" align="char" char="&#x000b1;">17.71&#x000a0;&#x000b1;&#x000a0;0.56**</td><td style="border:none;" align="char" char="&#x000b1;">19.68&#x000a0;&#x000b1;&#x000a0;0.91**</td><td style="border:none;" align="char" char="&#x000b1;">19.40&#x000a0;&#x000b1;&#x000a0;0.79**</td><td style="border:none;" align="char" char="&#x000b1;">18.99&#x000a0;&#x000b1;&#x000a0;1.21**</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">15</td><td style="border:none;" align="char" char="&#x000b1;">22.76&#x000a0;&#x000b1;&#x000a0;0.45***</td><td style="border:none;" align="char" char="&#x000b1;">22.90&#x000a0;&#x000b1;&#x000a0;1.00***</td><td style="border:none;" align="char" char="&#x000b1;">21.97&#x000a0;&#x000b1;&#x000a0;1.32***</td><td style="border:none;" align="char" char="&#x000b1;">21.99&#x000a0;&#x000b1;&#x000a0;1.40***</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>Data are presented as the mean &#x000b1;
SEM of animal tolerance to thermal stimuli in seconds. The level of
significance was determined by ANOVA followed by Dunnet&#x02019;s test.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec3.2"><label>3.2</label><title>Muscle
Relaxant Effect</title><p>The muscle coordination effect of compound <bold>1</bold> in both
experiments is presented in <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>. The muscle relaxant effect was significant at the
tested dose of 15 mg/kg in both experiments. The percentage of effect
at the higher dose was 43.76% at the early period, which was improved
up to 52.12% after 90 min postadministration (inclined plane). In
the case of the traction test, the same pattern of muscle coordination
effect was observed.</p><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>Muscle Relaxant
Effect of Compound <bold>1</bold> Isolated from <italic>F.
adenophylla</italic><xref rid="t2fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th style="border:none;" align="center">&#x000a0;</th><th colspan="3" align="center">inclined
plane test (%) time in minutes<hr/></th><th colspan="3" align="center">traction
test (%) time in minutes<hr/></th></tr><tr><th style="border:none;" align="center">group</th><th style="border:none;" align="center">dose mg/kg</th><th style="border:none;" align="center">30</th><th style="border:none;" align="center">60</th><th style="border:none;" align="center">90</th><th style="border:none;" align="center">30</th><th style="border:none;" align="center">60</th><th style="border:none;" align="center">90</th></tr></thead><tbody><tr><td style="border:none;" align="left">distilled
water</td><td style="border:none;" align="left">10&#x000a0;mL</td><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">diazepam</td><td style="border:none;" align="left">1</td><td style="border:none;" align="left">100&#x000a0;&#x000b1;&#x000a0;00</td><td style="border:none;" align="left">100&#x000a0;&#x000b1;&#x000a0;00</td><td style="border:none;" align="left">100&#x000a0;&#x000b1;&#x000a0;00</td><td style="border:none;" align="left">100&#x000a0;&#x000b1;&#x000a0;00</td><td style="border:none;" align="left">100&#x000a0;&#x000b1;&#x000a0;00</td><td style="border:none;" align="left">100&#x000a0;&#x000b1;&#x000a0;00</td></tr><tr><td style="border:none;" align="left">peshawaraquinone</td><td style="border:none;" align="left">2.5</td><td style="border:none;" align="left">18.30&#x000a0;&#x000b1;&#x000a0;1.88</td><td style="border:none;" align="left">24.57&#x000a0;&#x000b1;&#x000a0;1.76</td><td style="border:none;" align="left">23.58&#x000a0;&#x000b1;&#x000a0;1.78</td><td style="border:none;" align="left">19.28&#x000a0;&#x000b1;&#x000a0;1.57</td><td style="border:none;" align="left">24.66&#x000a0;&#x000b1;&#x000a0;2.12</td><td style="border:none;" align="left">23.98&#x000a0;&#x000b1;&#x000a0;2.88</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">5</td><td style="border:none;" align="left">25.45&#x000a0;&#x000b1;&#x000a0;2.00</td><td style="border:none;" align="left">34.87&#x000a0;&#x000b1;&#x000a0;2.54</td><td style="border:none;" align="left">35.80&#x000a0;&#x000b1;&#x000a0;2.60</td><td style="border:none;" align="left">26.65&#x000a0;&#x000b1;&#x000a0;2.19</td><td style="border:none;" align="left">34.12&#x000a0;&#x000b1;&#x000a0;2.40</td><td style="border:none;" align="left">35.58&#x000a0;&#x000b1;&#x000a0;2.88</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">10</td><td style="border:none;" align="left">32.87&#x000a0;&#x000b1;&#x000a0;1.93</td><td style="border:none;" align="left">43.98&#x000a0;&#x000b1;&#x000a0;2.00</td><td style="border:none;" align="left">44.12&#x000a0;&#x000b1;&#x000a0;2.01</td><td style="border:none;" align="left">33.40&#x000a0;&#x000b1;&#x000a0;2.44</td><td style="border:none;" align="left">45.12&#x000a0;&#x000b1;&#x000a0;2.64</td><td style="border:none;" align="left">44.55&#x000a0;&#x000b1;&#x000a0;2.90</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">15</td><td style="border:none;" align="left">43.76&#x000a0;&#x000b1;&#x000a0;2.21</td><td style="border:none;" align="left">51.56&#x000a0;&#x000b1;&#x000a0;2.76</td><td style="border:none;" align="left">52.12&#x000a0;&#x000b1;&#x000a0;2.88</td><td style="border:none;" align="left">44.20&#x000a0;&#x000b1;&#x000a0;2.12</td><td style="border:none;" align="left">52.96&#x000a0;&#x000b1;&#x000a0;2.22</td><td style="border:none;" align="left">51.90&#x000a0;&#x000b1;&#x000a0;2.40</td></tr></tbody></table><table-wrap-foot><fn id="t2fn1"><label>a</label><p>Data are presented
as the mean &#x000b1;
SEM of the percent effect.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec3.3"><label>3.3</label><title>Sedative Effect</title><p>Compound <bold>1</bold> significantly
hindered (<italic>p</italic> &#x0003c; 0.001) the movement of animals in
the special box, which reflects
its sedative potential (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>). The tested compound demonstrated significant (<italic>p</italic> &#x0003c; 0.01) effect. In comparison with the negative control, the
compound <bold>1</bold> restricted the movement of animals, indicating
the sedative effect.</p><table-wrap id="tbl3" position="float"><label>Table 3</label><caption><title>Effect of Compound <bold>1</bold> Isolated from <italic>F. adenophylla</italic> in the Open-Field Test (Locomotive Activity)<xref rid="t3fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="char" char="&#x000b1;"/></colgroup><thead><tr><th style="border:none;" align="center">sample</th><th style="border:none;" align="center">dose mg/kg</th><th style="border:none;" align="center" char="&#x000b1;">no of lines crossed</th></tr></thead><tbody><tr><td style="border:none;" align="left">control</td><td style="border:none;" align="left">5&#x000a0;mL</td><td style="border:none;" align="char" char="&#x000b1;">129.24&#x000a0;&#x000b1;&#x000a0;3.91</td></tr><tr><td style="border:none;" align="left">diazepam</td><td style="border:none;" align="left">0.5</td><td style="border:none;" align="char" char="&#x000b1;">9.00&#x000a0;&#x000b1;&#x000a0;0.55</td></tr><tr><td style="border:none;" align="left">peshawaraquinone</td><td style="border:none;" align="left">2.5</td><td style="border:none;" align="char" char="&#x000b1;">79.66&#x000a0;&#x000b1;&#x000a0;0.97**</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">5</td><td style="border:none;" align="char" char="&#x000b1;">70.41&#x000a0;&#x000b1;&#x000a0;1.24***</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">10</td><td style="border:none;" align="char" char="&#x000b1;">61.95&#x000a0;&#x000b1;&#x000a0;2.63***</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">15</td><td style="border:none;" align="char" char="&#x000b1;">52.01&#x000a0;&#x000b1;&#x000a0;3.26***</td></tr></tbody></table><table-wrap-foot><fn id="t3fn1"><label>a</label><p>Data are
presented as the mean &#x000b1;
SEM of the number of lines crossed by animals. The level of significance
was determined by ANOVA followed by Dunnet&#x02019;s test.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec3.4"><label>3.4</label><title>Acute Toxicity</title><p>During
the acute toxicity study, no mortality was observed at 200 mg/kg.</p></sec><sec id="sec3.5"><label>3.5</label><title>Molecular Docking Studies</title><p>We performed
molecular docking studies to explore the mechanism
of analgesic activity. Based on the mechanism of action of tramadol,
a standard drug used, we first performed docking studies on the &#x003bc;-opioid
receptor (&#x003bc;OR). For this purpose, we obtained the 3D crystal
structure of the &#x003bc;-opioid receptor with the native ligand BU72
(PDB id = 5C1M). The redocking process was carried out to assess the docking reliability.
After docking validation, the standard drug used in the current study,
that is, tramadol, was docked into the active site of 5C1M. Moreover, we also
analyzed the binding orientation and binding energy of the irreversible
morphinan antagonist &#x003b2;-funaltrexamine (&#x003b2;-FNA) (PDB-entry 4DKL). The 3D interaction
plots of the three studied drugs are shown in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>. The native ligand (BU72) with a binding
energy value of &#x02212;7.7408 kcal/mol interacts with His54 and Asp147 <italic>via</italic> hydrogen-bond interactions. Cys217 forms &#x003c0;-interactions
with the phenyl ring (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>a). Tramadol (&#x02212;6.6084 kcal/mol) formed one hydrogen-bond
interaction with Asp147. Tyr326 formed a &#x003c0;-alkyl interaction
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>b). The computed
binding energy of the antagonist &#x003b2;-FNA was &#x02212;8.6277 kcal/mol.
It formed two hydrogen-bond interactions with Asp147 and Lys303. Met151
formed &#x003c0;-sulfur interactions. The ligand enzyme complex was
stabilized by a &#x003c0;&#x02013;&#x003c3; interaction with Val300 (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>c).</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Close-up 3D interaction
plot of (a) native ligand BU72 and (b)
tramadol into the binding site of the &#x003bc;-opioid receptor 5C1M. (c) Binding interactions
of the &#x003bc;OR antagonist (from PDB id = 4DKL).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05720_0003" id="gr2" position="float"/></fig><p>Finally, we docked our isolated compound peshawaraquinone (<bold>1</bold>) into the binding site of 5C1M. Its superimposed binding pose with native
morphinan is shown in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>a. The 3D interaction plot showed two hydrogen-bond interactions
with Asp147 and Tyr326 <italic>via</italic> hydroxy groups. Tyr148
forms a bifurcated &#x003c0;&#x02013;&#x003c0; interaction with the naphthalene-1,4-dione
ring. Another bifurcated &#x003c0;&#x02013;&#x003c0; interaction was observed
between naphthalene-1,4-dione and Trp318 (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>b). Met151 displayed &#x003c0;-sulfur interactions.
The computed binding energy for the isolated compound was &#x02212;8.8430
kcal/mol.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>(a) Ribbon model of the superimposed binding poses of isolated
compound (pink) on the native drug (yellow) into the binding site
of 5C1M; (b)
close-up 3D interaction plot of the isolated compound into the binding
site of 5C1M.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05720_0004" id="gr3" position="float"/></fig><p>Subsequently, the muscle relaxant
effect of the isolated compound
was explored using docking simulations. The docking simulations were
carried out on GABAnergic receptors. The GABAnergic homopentamer from
humans was obtained from the Protein Data Bank (PDB id = 4COF). The receptor was
in complex with an agonist benzamidine located in each extracellular
domain (ECD).</p><p>The docking simulation of the standard drug diazepam
and isolated
compound was performed. The lowest energy 3D interaction plots of
the docked compounds are shown in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>. The nitrogen atom of the seven-membered
diazepam ring formed hydrogen-bond interactions with Gln64. The phenyl
ring forms &#x003c0;&#x02013;&#x003c0; interactions with Tyr62 (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>a). Our isolated
compound peshawaraquinone formed hydrogen-bond interactions with Gln64.
Similarly, naphthalene-1,4-dione formed &#x003c0;&#x02013;&#x003c0; interactions
with Tyr62 (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>a). Met115 formed &#x003c0;-alkyl interactions. The computed binding
energy values for diazepam and the isolated compound were &#x02212;5.6005
kcal/mol and &#x02212;5.9300 kcal/mol, respectively.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Close-up 3D interaction
plot of diazepam and (b) isolated compound
into the binding site of the GABA receptor (PDB id = 4COF).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05720_0005" id="gr4" position="float"/></fig></sec></sec><sec id="sec4"><label>4</label><title>Discussion</title><p>In Pakistan, alternative
medicines from <italic>F. adenophylla</italic> are locally
used for topical muscle relaxation and pain killer formulations.
The local community uses topical oil with <italic>F. adenophylla</italic> extract as one of the ingredients to relieve muscular tension and
pain. This folkloric practice encouraged us to test the currently
isolated molecule such as peshawaraquinone <bold>1</bold>, for pain
reliving, muscle coordination, and sedative effects. The testing of
chemical constituents against the folklore of medicinal plants is
a good push toward novel drug discovery. Even these biological experiments
provide a sound background to the extract.</p><p>Pain is considered
as a classic sign of the inflammation. A number
of chemical mediators are released during the inflammatory process.
These mediators cause nociceptive sensitization. Medicinal plants
are the main source of active phytochemicals that can be utilized
for the production of modern medicines.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Natural product-derived drugs and phytomedicine are becoming popular
compared to synthetic drugs because of their low cost and fewer side
effects. de Oliveira <italic>et al.</italic> studied the antinociceptive
properties of Bergenin, a C-glucoside of 4-O-methylgallic acid that
occurs naturally in several plant genera. The study showed that bergenin
has consistent antinociceptive and anti-inflammatory properties.<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> Martins <italic>et al.</italic> isolated (&#x02212;)-4&#x02032;-methylepigallocattechin
from Maytenus rigida Mart. which demonstrated the antinociceptive
activity in mice.<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> Rodrigues <italic>et
al.</italic> investigated the antinociceptive effect of three alkaloids
(dihydro-piplartine, piplartine, and 3,4,5-trimethoxydihydrocinnamic
acid) and crude extracts from the fruits of <italic>Piper tuberculatum</italic> J<sub>ACQ</sub> (Piperaceae).<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> Similarly,
essential oils and their monoterpenes/sesquiterpenes possess analgesic
properties. Lenard&#x000e3;o <italic>et al.</italic> compiled antinociceptive
of about 63 essential oils and their constituents.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup></p><p>Naphthoquinones are structurally diverse secondary
metabolites
found in bacteria, fungi, and higher plants and exhibited several
biological activities including anti-inflammatory and antinociceptive
activity. Soares <italic>et al.</italic> for the first time explored
the anti-inflammatory and antinociceptive activity of five naphthoquinones
isolated from tubers of <italic>Sinningia reitzii</italic>.<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> Considering the key role of natural
products especially naphthoquinones in nociception, we planned the
study to evaluate peshawaraquinone <bold>1</bold> for its central
analgesic, muscle relaxant, and sedative effects. Compound <bold>1</bold> belongs to the naphthoquinone class of chemical constituents, which
have been reported to have various biological activities, such as
anticancer, sedative, analgesic, and antimicrobial activities. The
structure of peshawaraquinone <bold>1</bold> bears minor resemblance
with benzodiazepines which are significant sedative hypnotic, muscle
relaxant, and adjuvant analgesics.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> The
biological actions of benzodiazepines are attributed to their strong
interactions with GABA channels.<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> Once
the GABA channels are occupied at allosteric sites, the chloride channel
opens, and more chloride influx occurs, which shifts the membrane
potential toward being more electronegative, and the cell becomes
inhibited. Once the membrane potential becomes more electronegative,
the calcium channels remain closed, and no calcium influx occurs.
These intracellular cascades hinder the release of neurotransmitters
and thus mitigate the interactions of neurotransmitters with postsynoptic
receptors. This attenuated situation keeps the muscles relaxed and
induces sedation, decreasing pain sensation. The significant analgesic
potential of peshawaraquinone <bold>1</bold> might be due to the interaction
with GABA channels or with opioid receptors. If peshawaraquinone <bold>1</bold> is considered an agonist for opioid receptors, it might
be a muscle relaxant.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> Opioid receptors
are known as G protein-coupled receptors (GPCRs). Once an agonist
binds with these inhibitory heptahelical receptors, intracellular
signaling inhibits protein kinase A and stimulates the potassium channel
to stay open, and more potassium efflux occurs, which causes the membrane
potential to become more electronegative. Again, calcium channels
are not opening, and no calcium is available for neurotransmitter
exocytosis. Once the exocytosis of neurotransmitters (especially substance
p) diminishes, the pain threshold level is set to convert algesia
into analgesia. These cascades show potential muscle relaxation effects
and probably sedative effects as well.</p><p>Computational studies
have led to the developing of new drugs especially
analgesics. Docking simulations predict the binding orientation of
a compound of therapeutic interest into the active site of the target
and also helps in understanding the biological activity. Moreover,
the binding orientations and interactions also help in structure&#x02013;activity
relationship (SAR) studies. Computational docking simulations demonstrated
that the isolated compound (<bold>1</bold>) has shown favorable binding
orientations and binding energy values against the &#x003bc;-opioid
and GABAnergic receptors. The &#x003bc;-opioid receptors (&#x003bc;ORs)
are membrane proteins and members of the opioid neuromodulatory system.
These receptors are the therapeutic targets of opioid drugs for the
treatment of moderate to severe pain. However, the binding pattern
of &#x003bc;OR-targeting drugs (antagonist <italic>vs</italic> agonist)
is not unclear. There are some hypotheses about the substitution pattern
at the nitrogen atom on these receptors. It is assumed that bulky
groups such as allyl or cyclopropylmethyl are associated with antagonist
activity. The N-methyl group is considered to show agonist properties.<sup><xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref35">35</xref></sup> However, there are a number of examples displaying agonist activity
with bulky groups on nitrogen atoms.<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref37">37</xref></sup></p><p>Describing
&#x003bc;OR interactions helps us to identify the responses
and initiate the selective activation of signaling pathways which
may be exploited to develop novel and potent anti-inflammatory agents/analgesics.
The solved crystal structures of &#x003bc;OR-bound antagonists and agonists
provided a detailed analysis of the ligand&#x02013;receptor-binding
pattern. The first three-dimensional structure of &#x003bc;OR in complex
with the irreversible antagonist &#x003b2;-FNA was published in 2012
(PDB ID = 4DKL). The antagonist displayed hydrogen-bond interactions with Asp147
and Tyr148. It was also involved in hydrophobic interactions with
Met151, Tro293, Ile296, and Val300.<sup><xref ref-type="bibr" rid="ref38">38</xref>,<xref ref-type="bibr" rid="ref39">39</xref></sup> Later, insights
into the binding pattern of the agonist BU72 into the binding site
of &#x003bc;ORs were published.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> The agonist
BU72 showed hydrogen-bond interactions with Asp147, Tyr148 (water-mediated),
and His54.</p><p>It is interesting to note that SAR studies revealed
that a slight
change in the structure of compound can convert an agonist to antagonist.
We performed docking analysis by comparing the binding poses of the
compound under study with an antagonist- and agonist-binding pattern.
The detailed binding-pose analysis and binding-energy calculations
of our isolated compound <bold>1</bold> allowed us to gain further
insights into its mode of action. Structurally, compound <bold>1</bold> is a structurally diverse compound with fused rings. The binding
energies for agonist, tramadol, antagonist, and compound <bold>1</bold> are &#x02212;7.7408, 6.6084, &#x02212;8.6277, and &#x02212;8.8430 kcal/mol,
respectively. This shows that our compound binds more tightly than
the other studied compounds. As far as the binding interaction is
concerned, it forms two hydrogen-bond interactions with Asp147 and
Tyr326. Hydrophobic interactions were also observed with Tyr148 and
Met 151. However, detailed experimental data related to the mechanism
of action of structurally diverse ligands are required.</p><p>The
possible mechanism behind these pharmacological actions might
be interaction with GABA or opioids, as discussed above. However,
to find safe, effective, and nonaddictive molecules, peshawaraquinone <bold>1</bold> must be subjected to structure&#x02013;activity relationship
(SAR) analysis and a detailed mechanistic study.</p></sec><sec id="sec5"><label>5</label><title>Conclusions</title><p>In the current study, peshawaraquinone 1 isolated from <italic>F. adenophylla</italic> demonstrated significant analgesic,
sedative, and muscle relaxant effects. The traditional use of <italic>F. adenophylla</italic> is mainly in massage oils, which are
supposed to comfort muscular tension and pain. The traditional usage
of this plant was strongly augmented by peshawaraquinone 1. Thus,
our findings provide scientific rationale for the folkloric usage
of <italic>F. adenophylla</italic> for the treatment
of various diseases. Thus, peshawaraquinone 1 is a novel candidate
for additional detailed study to ascertain its clinical use. A detailed
comparison of the binding orientations and binding energy values computed
through docking was carried out among agonists, antagonists, and the
isolated compound. The interactions of peshawaraquinone 1 with pharmacological
targets suggest that the compound may act as a novel nociceptive and
inflammatory pain alleviator, as supported by <italic>in vivo</italic> studies.</p></sec></body><back><notes id="notes1" notes-type="si"><title>Supporting Information Available</title><p>The Supporting Information is
available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acsomega.0c05720?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsomega.0c05720</ext-link>.<list id="silist" list-type="simple"><list-item><p>Spectroscopic data associated
to this paper have been
provided as supplementary file (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c05720/suppl_file/ao0c05720_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05720_si_001.pdf"><caption><p>ao0c05720_si_001.pdf</p></caption></media></supplementary-material></sec><notes notes-type="" id="notes2"><title>Author Contributions</title><p>Conceptualization,
F.A.A.; methodology, A.S.M.A.; software, U.R.; validation, Z.A.S.;
formal analysis, A.R.; investigation, N.M.; resources, Y.S.A.-A.;
and data curation and original draft preparation, O.S.B. All authors
have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="COI-statement" id="NOTES-d7e1362-autogenerated"><p>The authors declare no
competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>The researchers
would like to thank the Deanship
of Scientific Research, Qassim University, for funding publication
of this project.</p></ack><glossary id="dl1"><def-list><title>Abbreviations</title><def-item><term><italic>F. adenophylla</italic></term><def><p><italic>Fernandoa adenophylla</italic></p></def></def-item><def-item><term>TLC</term><def><p>thin layer chromatography</p></def></def-item><def-item><term>MOE</term><def><p>molecular operating
environment (MOE)</p></def></def-item><def-item><term>PDB</term><def><p>Protein Data Bank</p></def></def-item><def-item><term>rmsd</term><def><p>root-mean-square deviation</p></def></def-item><def-item><term>3D</term><def><p>three-dimensional</p></def></def-item><def-item><term>ECD</term><def><p>extracellular domain</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="book" id="cit1"><person-group person-group-type="allauthors"><name><surname>Patrick</surname><given-names>G. L.</given-names></name></person-group><source>An Introduction to
Medicinal Chemistry</source>, <edition>5</edition>th ed.; <publisher-name>Oxford University Press</publisher-name>: <publisher-loc>United Kingdom</publisher-loc>, <year>2013</year>; pp <fpage>1</fpage>&#x02013;<lpage>789</lpage>.</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Johann</surname><given-names>S.</given-names></name>; <name><surname>Pizzolatti</surname><given-names>M. G.</given-names></name>; <name><surname>Donnici</surname><given-names>C. L.</given-names></name>; <name><surname>Resende</surname><given-names>M. A. D.</given-names></name>
<article-title>Antifungal properties
of plants used in Brazilian traditional medicine against clinically
relevant fungal pathogens</article-title>. <source>Braz. J. Microbiol.</source>
<year>2007</year>, <volume>38</volume>, <fpage>632</fpage>&#x02013;<lpage>637</lpage>. <pub-id pub-id-type="doi">10.1590/s1517-83822007000400010</pub-id>.</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Farombi</surname><given-names>E. O.</given-names></name>
<article-title>African
indigenous plants with chemotherapeutic potentials and biotechnological
approach to the production of bioactive prophylactic agents</article-title>. <source>Afr. J. Biotechnol.</source>
<year>2003</year>, <volume>2</volume>, <fpage>662</fpage>&#x02013;<lpage>671</lpage>. <pub-id pub-id-type="doi">10.5897/ajb2003.000-1122</pub-id>.</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Teklehaymanot</surname><given-names>T.</given-names></name>; <name><surname>Giday</surname><given-names>M.</given-names></name>
<article-title>Ethnobotanical study
of medicinal plants used by people in Zegie
Peninsula, Northwestern Ethiopia</article-title>. <source>J. Ethnobiol.
Ethnomed.</source>
<year>2007</year>, <volume>3</volume>, <fpage>12</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1186/1746-4269-3-12</pub-id>.<pub-id pub-id-type="pmid">17355645</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Srinivasan</surname><given-names>K.</given-names></name>; <name><surname>Natarajan</surname><given-names>D.</given-names></name>; <name><surname>Mohanasundari</surname><given-names>C.</given-names></name>; <name><surname>Venkatakrishnan</surname><given-names>C.</given-names></name>; <name><surname>Nagamurugan</surname><given-names>N.</given-names></name>
<article-title>Antibacterial,
preliminary phytochemical and pharmacognostical
screening on the leaves of Vicoa indica (L.) DC</article-title>. <source>J. Pharmacol. Exp. Therapeut.</source>
<year>2007</year>, <volume>6</volume>, <fpage>109</fpage>&#x02013;<lpage>113</lpage>.</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Ullah</surname><given-names>Z.</given-names></name>; <name><surname>Ata-ur-Rahman</surname></name>; <name><surname>Fazl-i-Sattar</surname></name>; <name><surname>Rauf</surname><given-names>A.</given-names></name>; <name><surname>Yaseen</surname><given-names>M.</given-names></name>; <name><surname>Hassan</surname><given-names>W.</given-names></name>; <name><surname>Tariq</surname><given-names>M.</given-names></name>; <name><surname>Ayub</surname><given-names>K.</given-names></name>; <name><surname>Tahir</surname><given-names>A. A.</given-names></name>; <name><surname>Ullah</surname><given-names>H.</given-names></name>
<article-title>Density Functional
Theory and Phytochemical Study of 8-Hydroxyisodiospyrin</article-title>. <source>J. Mol. Struct.</source>
<year>2015</year>, <volume>1095</volume>, <fpage>69</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2015.04.027</pub-id>.</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Fazl-i-Sattar</surname></name>; <name><surname>Ullah</surname><given-names>Z.</given-names></name>; <name><surname>Ata-ur-Rahman</surname></name>; <name><surname>Rauf</surname><given-names>A.</given-names></name>; <name><surname>Tariq</surname><given-names>M.</given-names></name>; <name><surname>Tahir</surname><given-names>A. A.</given-names></name>; <name><surname>Ayub</surname><given-names>K.</given-names></name>; <name><surname>Ullah</surname><given-names>H.</given-names></name>
<article-title>Phytochemical, Spectroscopic
and Density Functional Theory Study of Diospyrin, and Non-bonding
Interactions of Diospyrin with Atmospheric Gases</article-title>. <source>Spectrochim. Acta, Part A</source>
<year>2015</year>, <volume>141</volume>, <fpage>71</fpage>&#x02013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/j.saa.2015.01.022</pub-id>.</mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Habib</surname><given-names>U.</given-names></name>; <name><surname>Rauf</surname><given-names>A.</given-names></name>; <name><surname>Ullah</surname><given-names>Z.</given-names></name>; <name><surname>Fazl-i-Sattar</surname></name>; <name><surname>Anwar</surname><given-names>M.</given-names></name>; <name><surname>Shah</surname><given-names>A-u-H. H.</given-names></name>; <name><surname>Uddin</surname><given-names>G.</given-names></name>; <name><surname>Ayub</surname><given-names>K.</given-names></name>
<article-title>Density functional
theory and phytochemical
study of Pistagremic acid</article-title>. <source>Spectrochim. Acta,
Part A</source>
<year>2014</year>, <volume>118</volume>, <fpage>210</fpage>&#x02013;<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1016/j.saa.2013.08.099</pub-id>.</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Shah</surname><given-names>Z. A.</given-names></name>; <name><surname>Khan</surname><given-names>M. R.</given-names></name>
<article-title>Peshawaraquinone
a Novel Naphthoquinone and a New Indanone
from the stem of Heterophragma adenophyllum Seem</article-title>. <source>Rec. Nat. Prod.</source>
<year>2015</year>, <volume>9</volume>, <fpage>169</fpage>&#x02013;<lpage>174</lpage>.</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Jassbi</surname><given-names>A. R.</given-names></name>; <name><surname>Singh</surname><given-names>P.</given-names></name>; <name><surname>Jain</surname><given-names>S.</given-names></name>; <name><surname>Tahara</surname><given-names>S.</given-names></name>
<article-title>Novel Naphthoquinones
fromHeterophragma adenophyllum</article-title>. <source>Helv. Chim.
Acta</source>
<year>2004</year>, <volume>87</volume>, <fpage>820</fpage>&#x02013;<lpage>824</lpage>. <pub-id pub-id-type="doi">10.1002/hlca.200490080</pub-id>.</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><person-group person-group-type="allauthors"><name><surname>Chorsiya</surname><given-names>A.</given-names></name>; <name><surname>Singh</surname><given-names>M.
V.</given-names></name>; <name><surname>Khasimbi</surname><given-names>S.</given-names></name></person-group><article-title>Fernandoa Adenophylla:
A review of its Phytochemistry, Traditional and Pharmacology use and
Future Aspects</article-title>. <source>Curr. Tradit. Med.</source><year>2020</year>, <volume>06</volume>.<pub-id pub-id-type="doi">10.2174/2215083806999200729104850</pub-id>.</mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Rahmatullah</surname><given-names>M.</given-names></name>; <name><surname>Samarrai</surname><given-names>W.</given-names></name>; <name><surname>Jahan</surname><given-names>R.</given-names></name>; <name><surname>Rahman</surname><given-names>S.</given-names></name>; <name><surname>Sharmin</surname><given-names>N.</given-names></name>; <name><surname>Miajee</surname><given-names>E. U.</given-names></name>; <name><surname>Chowdhury</surname><given-names>MH.</given-names></name>; <name><surname>Bari</surname><given-names>S.</given-names></name>; <name><surname>Jamal</surname><given-names>F.</given-names></name>; <name><surname>Bashar</surname><given-names>A.</given-names></name>; <name><surname>Azad</surname><given-names>A. K.</given-names></name>; <name><surname>Ahsan</surname><given-names>S.</given-names></name>
<article-title>An ethnomedicinal,
pharmacological and phytochemical review of some Bignoniaceae family
plants and a description of Bignoniaceae plants in folk medicinal
uses in Bangladesh</article-title>. <source>Adv. Life Sci.</source>
<year>2010</year>, <volume>4</volume>, <fpage>236</fpage>&#x02013;<lpage>241</lpage>.</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Rao</surname><given-names>K. V.</given-names></name>; <name><surname>Mcbride</surname><given-names>T. J.</given-names></name>; <name><surname>Oleson</surname><given-names>J. J.</given-names></name>
<article-title>Recognition
and evaluation of lapachol
as an antitumor agent</article-title>. <source>Cancer Res.</source>
<year>1968</year>, <volume>28</volume>, <fpage>1952</fpage>&#x02013;<lpage>1954</lpage>.</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Balassiano</surname><given-names>I. T.</given-names></name>; <name><surname>De Paulo</surname><given-names>S. A.</given-names></name>; <name><surname>Henriques
Silva</surname><given-names>N.</given-names></name>; <name><surname>Cabral</surname><given-names>M. C.</given-names></name>; <name><surname>da Gloria
da Costa Carvalho</surname><given-names>M.</given-names></name>
<article-title>Demonstration of the lapachol as a potential drug for
reducing cancer metastasis</article-title>. <source>Oncol. Rep.</source>
<year>2005</year>, <volume>13</volume>, <fpage>329</fpage>&#x02013;<lpage>233</lpage>. <pub-id pub-id-type="doi">10.3892/or.13.2.329</pub-id>.<pub-id pub-id-type="pmid">15643520</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Hussain</surname><given-names>H.</given-names></name>; <name><surname>Krohan</surname><given-names>K.</given-names></name>; <name><surname>Ahmad</surname><given-names>V. U.</given-names></name>; <name><surname>Miana</surname><given-names>G. A.</given-names></name>
<article-title>Lapachol:
an overview</article-title>. <source>Arkivoc</source>
<year>2007</year>, <volume>2</volume>, <fpage>145</fpage>&#x02013;<lpage>171</lpage>. <pub-id pub-id-type="doi">10.3998/ark.5550190.0008.204</pub-id>.</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Rauf</surname><given-names>A.</given-names></name>; <name><surname>Abu-Izneid</surname><given-names>T.</given-names></name>; <name><surname>Maalik</surname><given-names>A.</given-names></name>; <name><surname>Bawazeer</surname><given-names>S.</given-names></name>; <name><surname>Khan</surname><given-names>A.</given-names></name>; <name><surname>Hadda</surname><given-names>T. B.</given-names></name>; <name><surname>Khan</surname><given-names>H.</given-names></name>; <name><surname>Ramadan</surname><given-names>M. F.</given-names></name>; <name><surname>Khan</surname><given-names>I.</given-names></name>; <name><surname>Mubarak</surname><given-names>M. S.</given-names></name>; <name><surname>Uddin</surname><given-names>G.</given-names></name>; <name><surname>Bahadar</surname><given-names>A.</given-names></name>; <name><surname>Farooq</surname><given-names>U.</given-names></name>
<article-title>Gastrointestinal
Motility and Acute Toxicity of Pistagremic acid Isolated from the
Galls of Pistacia integerrima</article-title>. <source>Med. Chem.</source>
<year>2017</year>, <volume>13</volume>, <fpage>292</fpage>&#x02013;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.2174/1573406412666161007145247</pub-id>.<pub-id pub-id-type="pmid">27748181</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Rauf</surname><given-names>A.</given-names></name>; <name><surname>Maione</surname><given-names>F.</given-names></name>; <name><surname>Uddin</surname><given-names>G.</given-names></name>; <name><surname>Raza</surname><given-names>M.</given-names></name>; <name><surname>Siddiqui</surname><given-names>B. S.</given-names></name>; <name><surname>Muhammad</surname><given-names>N.</given-names></name>; <name><surname>Shah</surname><given-names>S. U. A.</given-names></name>; <name><surname>Khan</surname><given-names>H.</given-names></name>; <name><surname>De Feo</surname><given-names>V.</given-names></name>; <name><surname>Mascolo</surname><given-names>N.</given-names></name>
<article-title>Biological Evaluation
and Docking Analysis of Daturaolone
as Potential Cyclooxygenase Inhibitor</article-title>. <source>J. Evidence-Based
Complementary Altern. Med.</source>
<year>2016</year>, <volume>2016</volume>, <fpage>4098686</fpage><pub-id pub-id-type="doi">10.1155/2016/4098686</pub-id>.</mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Muhammad</surname><given-names>N.</given-names></name>; <name><surname>Lal Shrestha</surname><given-names>R.</given-names></name>; <name><surname>Adhikari</surname><given-names>A.</given-names></name>; <name><surname>Wadood</surname><given-names>A.</given-names></name>; <name><surname>Khan</surname><given-names>H.</given-names></name>; <name><surname>Khan</surname><given-names>A. Z.</given-names></name>; <name><surname>Maione</surname><given-names>F.</given-names></name>; <name><surname>Mascolo</surname><given-names>N.</given-names></name>; <name><surname>De Feo</surname><given-names>V.</given-names></name>
<article-title>First evidence
of the analgesic activity of govaniadine, an alkaloid isolated fromCorydalis
govanianaWall</article-title>. <source>Nat. Prod. Res.</source>
<year>2015</year>, <volume>29</volume>, <fpage>430</fpage>&#x02013;<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1080/14786419.2014.951933</pub-id>.<pub-id pub-id-type="pmid">25154594</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Reddy</surname><given-names>S.</given-names></name>; <name><surname>Patt</surname><given-names>R. B.</given-names></name>
<article-title>The benzodiazepines as adjuvant analgesics</article-title>. <source>J. Pain Symptom Manag.</source>
<year>1994</year>, <volume>9</volume>, <fpage>510</fpage>&#x02013;<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1016/0885-3924(94)90112-0</pub-id>.</mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Rauf</surname><given-names>A.</given-names></name>; <name><surname>Bawazeer</surname><given-names>S.</given-names></name>; <name><surname>Uddin</surname><given-names>G.</given-names></name>; <name><surname>Siddiqui</surname><given-names>B. S.</given-names></name>; <name><surname>Khan</surname><given-names>H.</given-names></name>; <name><surname>Ben Hadda</surname><given-names>T.</given-names></name>; <name><surname>Mabkhot</surname><given-names>Y. N.</given-names></name>; <name><surname>Shaheen</surname><given-names>U.</given-names></name>; <name><surname>Ramadan</surname><given-names>M. F.</given-names></name>
<article-title>Muscle
relaxant activities of pistagremic acid isolated from Pistacia integerrima</article-title>. <source>Z. Naturforsch., C: J. Biosci.</source>
<year>2018</year>, <volume>73</volume>, <fpage>413</fpage>&#x02013;<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1515/znc-2017-0179</pub-id>.<pub-id pub-id-type="pmid">30265657</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Abu-Izneid</surname><given-names>T.</given-names></name>; <name><surname>Rauf</surname><given-names>A.</given-names></name>; <name><surname>Shah</surname><given-names>S. U. A.</given-names></name>; <name><surname>Wadood</surname><given-names>A.</given-names></name>; <name><surname>Abdelhady</surname><given-names>M. I. S.</given-names></name>; <name><surname>Nathalie</surname><given-names>P.</given-names></name>; <name><surname>C&#x000e9;line</surname><given-names>D.</given-names></name>; <name><surname>Mansour</surname><given-names>N.</given-names></name>; <name><surname>Patel</surname><given-names>S.</given-names></name>
<article-title>In Vivo Study
on Analgesic, Muscle-Relaxant, Sedative Activity of Extracts of Hypochaeris
radicata and In Silico Evaluation of Certain Compounds Present in
This Species</article-title>. <source>Biomed Res. Int.</source>
<year>2018</year>, <volume>2018</volume>, <fpage>3868070</fpage><pub-id pub-id-type="doi">10.1155/2018/3868070</pub-id>.<pub-id pub-id-type="pmid">29992141</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Velasco-Chong</surname><given-names>J. R.</given-names></name>; <name><surname>Herrera-Calder&#x000f3;n</surname><given-names>O.</given-names></name>; <name><surname>Rojas-Armas</surname><given-names>J. P.</given-names></name>; <name><surname>Ha&#x000f1;ari-Quispe</surname><given-names>R. D.</given-names></name>; <name><surname>Figueroa-Salvador</surname><given-names>L.</given-names></name>; <name><surname>Pe&#x000f1;a-Rojas</surname><given-names>G.</given-names></name>; <name><surname>And&#x000ed;a-Ayme</surname><given-names>V.</given-names></name>; <name><surname>Yuli-Posadas</surname><given-names>R. &#x000c1;.</given-names></name>; <name><surname>Yepes-Perez</surname><given-names>A. F.</given-names></name>; <name><surname>Aguilar</surname><given-names>C.</given-names></name>
<article-title>TOCOSH FLOUR (Solanum
tuberosum L.): A Toxicological Assessment of Traditional Peruvian
Fermented Potatoes</article-title>. <source>Food</source>
<year>2020</year>, <volume>9</volume>, <fpage>719</fpage><pub-id pub-id-type="doi">10.3390/foods9060719</pub-id>.</mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Rauf</surname><given-names>A.</given-names></name>; <name><surname>Abu-Izneid</surname><given-names>T.</given-names></name>; <name><surname>Rashid</surname><given-names>U.</given-names></name>; <name><surname>Alhumaydhi</surname><given-names>F. A.</given-names></name>; <name><surname>Bawazeer</surname><given-names>S.</given-names></name>; <name><surname>Khalil</surname><given-names>A. A.</given-names></name>; <name><surname>Aljohani</surname><given-names>A. S. M.</given-names></name>; <name><surname>Abdallah</surname><given-names>E. M.</given-names></name>; <name><surname>Al-Tawaha</surname><given-names>A. R.</given-names></name>; <name><surname>Mabkhot</surname><given-names>Y. N.</given-names></name>; <name><surname>Shariati</surname><given-names>M. A.</given-names></name>; <name><surname>Plygun</surname><given-names>S.</given-names></name>; <name><surname>Uddin</surname><given-names>M. S.</given-names></name>; <name><surname>Ntsefong</surname><given-names>G. N.</given-names></name>
<article-title>Anti-inflammatory, Antibacterial,
Toxicological Profile, and In Silico Studies of Dimeric Naphthoquinones
from Diospyros lotus</article-title>. <source>BioMed Res. Int.</source>
<year>2020</year>, <volume>2020</volume>, <fpage>7942549</fpage><pub-id pub-id-type="doi">10.1155/2020/7942549</pub-id>.</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Jan</surname><given-names>M. S.</given-names></name>; <name><surname>Ahmad</surname><given-names>S.</given-names></name>; <name><surname>Hussain</surname><given-names>F.</given-names></name>; <name><surname>Ahmad</surname><given-names>A.</given-names></name>; <name><surname>Mahmood</surname><given-names>F.</given-names></name>; <name><surname>Rashid</surname><given-names>U.</given-names></name>; <name><surname>Abid</surname><given-names>O.-u. -R.</given-names></name>; <name><surname>Ullah</surname><given-names>F.</given-names></name>; <name><surname>Ayaz</surname><given-names>M.</given-names></name>; <name><surname>Sadiq</surname><given-names>A.</given-names></name>
<article-title>Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2,5-dione
derivatives as multitarget anti-inflammatory agents</article-title>. <source>Eur. J. Med. Chem.</source>
<year>2020</year>, <volume>186</volume>, <fpage>111863</fpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2019.111863</pub-id>.<pub-id pub-id-type="pmid">31740050</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Tanoli</surname><given-names>S. T.</given-names></name>; <name><surname>Ramzan</surname><given-names>M.</given-names></name>; <name><surname>Hassan</surname><given-names>A.</given-names></name>; <name><surname>Sadiq</surname><given-names>A.</given-names></name>; <name><surname>Jan</surname><given-names>M. S.</given-names></name>; <name><surname>Khan</surname><given-names>F. A.</given-names></name>; <name><surname>Ullah</surname><given-names>F.</given-names></name>; <name><surname>Ahmad</surname><given-names>H.</given-names></name>; <name><surname>Bibi</surname><given-names>M.</given-names></name>; <name><surname>Mahmood</surname><given-names>T.</given-names></name>; <name><surname>Rashid</surname><given-names>U.</given-names></name>
<article-title>Design, synthesis
and bioevaluation
of tricyclic fused ring system as dual binding site acetylcholinesterase
inhibitors</article-title>. <source>Bioorg. Chem.</source>
<year>2019</year>, <volume>83</volume>, <fpage>336</fpage>&#x02013;<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1016/j.bioorg.2018.10.035</pub-id>.<pub-id pub-id-type="pmid">30399465</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Iftikhar</surname><given-names>F.</given-names></name>; <name><surname>Yaqoob</surname><given-names>F.</given-names></name>; <name><surname>Tabassum</surname><given-names>N.</given-names></name>; <name><surname>Jan</surname><given-names>M. S.</given-names></name>; <name><surname>Sadiq</surname><given-names>A.</given-names></name>; <name><surname>Tahir</surname><given-names>S.</given-names></name>; <name><surname>Batool</surname><given-names>T.</given-names></name>; <name><surname>Niaz</surname><given-names>B.</given-names></name>; <name><surname>Ansari</surname><given-names>F. L.</given-names></name>; <name><surname>Choudhary</surname><given-names>M. I.</given-names></name>; <name><surname>Rashid</surname><given-names>U.</given-names></name>
<article-title>Design, synthesis,
in-vitro thymidine
phosphorylase inhibition, in-vivo antiangiogenic and in-silico studies
of C-6 substituted dihydropyrimidines</article-title>. <source>Bioorg.
Chem.</source>
<year>2018</year>, <volume>80</volume>, <fpage>99</fpage>&#x02013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/j.bioorg.2018.05.026</pub-id>.<pub-id pub-id-type="pmid">29894893</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Farooq</surname><given-names>U.</given-names></name>; <name><surname>Naz</surname><given-names>S.</given-names></name>; <name><surname>Shams</surname><given-names>A.</given-names></name>; <name><surname>Raza</surname><given-names>Y.</given-names></name>; <name><surname>Ahmed</surname><given-names>A.</given-names></name>; <name><surname>Rashid</surname><given-names>U.</given-names></name>; <name><surname>Sadiq</surname><given-names>A.</given-names></name>
<article-title>Isolation
of dihydrobenzofuran derivatives from ethnomedicinal species
Polygonum barbatum as anticancer compounds</article-title>. <source>Biol. Res.</source>
<year>2019</year>, <volume>52</volume>, <fpage>1</fpage><pub-id pub-id-type="doi">10.1186/s40659-018-0209-0</pub-id>.<pub-id pub-id-type="pmid">30612577</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>de
Oliveira</surname><given-names>C. M.</given-names></name>; <name><surname>Nonato</surname><given-names>F. R.</given-names></name>; <name><surname>de Lima</surname><given-names>F. O.</given-names></name>; <name><surname>Couto</surname><given-names>R. D.</given-names></name>; <name><surname>David</surname><given-names>J. P.</given-names></name>; <name><surname>David</surname><given-names>J. M.</given-names></name>; <name><surname>Soares</surname><given-names>M. B. P.</given-names></name>; <name><surname>Villarreal</surname><given-names>C. F.</given-names></name>
<article-title>Antinociceptive
properties of bergenin</article-title>. <source>J. Nat. Prod.</source>
<year>2011</year>, <volume>74</volume>, <fpage>2062</fpage>&#x02013;<lpage>2068</lpage>. <pub-id pub-id-type="doi">10.1021/np200232s</pub-id>.<pub-id pub-id-type="pmid">21939182</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Martins</surname><given-names>M. V.</given-names></name>; <name><surname>Estevam</surname><given-names>C. D. S.</given-names></name>; <name><surname>Santos</surname><given-names>A. L. L. M.</given-names></name>; <name><surname>Dias</surname><given-names>A. S.</given-names></name>; <name><surname>Cupertino-da-Silva</surname><given-names>Y. K.</given-names></name>; et al. <article-title>Antinociceptive effects of an extract, fraction and an isolated compound
of the stem bark of Maytenus rigida</article-title>. <source>Rev. Bras.
Farmacogn.</source>
<year>2012</year>, <volume>22</volume>, <fpage>598</fpage>&#x02013;<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1590/s0102-695x2012005000007</pub-id>.</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Rodrigues</surname><given-names>R. V.</given-names></name>; <name><surname>Lanznaster</surname><given-names>D.</given-names></name>; <name><surname>Longhi Balbinot</surname><given-names>D. T.</given-names></name>; <name><surname>Gadotti</surname><given-names>V. D. M.</given-names></name>; <name><surname>Facundo</surname><given-names>V. A.</given-names></name>; <name><surname>Santos</surname><given-names>A. R. S.</given-names></name>
<article-title>Antinociceptive
effect of crude extract, fractions
and three alkaloids obtained from fruits of Piper tuberculatum</article-title>. <source>Biol. Pharm. Bull.</source>
<year>2009</year>, <volume>32</volume>, <fpage>1809</fpage>&#x02013;<lpage>1812</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.32.1809</pub-id>.<pub-id pub-id-type="pmid">19801849</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Lenard&#x000e3;o</surname><given-names>E. J.</given-names></name>; <name><surname>Savegnago</surname><given-names>S.</given-names></name>; <name><surname>Jacob</surname><given-names>R. G.</given-names></name>; <name><surname>Victoriaa</surname><given-names>F. N.</given-names></name>; <name><surname>Martineza</surname><given-names>D. M.</given-names></name>
<article-title>Antinociceptive Effect of Essential Oils and Their
Constituents: an Update Review</article-title>. <source>J. Braz. Chem.
Soc.</source>
<year>2016</year>, <volume>27</volume>, <fpage>435</fpage>&#x02013;<lpage>474</lpage>. <pub-id pub-id-type="doi">10.5935/0103-5053.20150332</pub-id>.</mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Soares</surname><given-names>A. S.</given-names></name>; <name><surname>Barbosa</surname><given-names>F. L.</given-names></name>; <name><surname>R&#x000fc;diger</surname><given-names>A. L.</given-names></name>; <name><surname>Hughes</surname><given-names>D. L.</given-names></name>; <name><surname>Salvador</surname><given-names>M. J.</given-names></name>; <name><surname>Zampronio</surname><given-names>A. R.</given-names></name>; <name><surname>Stefanello</surname><given-names>M. &#x000c9;.
A.</given-names></name>
<article-title>Naphthoquinones of Sinningia
reitzii and Anti-inflammatory/Antinociceptive Activities of 8-Hydroxydehydrodunnione</article-title>. <source>J. Nat. Prod.</source>
<year>2017</year>, <volume>80</volume>, <fpage>1837</fpage>&#x02013;<lpage>1843</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.6b01186</pub-id>.<pub-id pub-id-type="pmid">28598175</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Olsen</surname><given-names>R. W.</given-names></name>
<article-title>GABA-Benzodiazepine-Barbiturate
Receptor Interactions</article-title>. <source>J. Neurochem.</source>
<year>1981</year>, <volume>37</volume>, <fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.1981.tb05284.x</pub-id>.<pub-id pub-id-type="pmid">6265597</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Tagaya</surname><given-names>E.</given-names></name>; <name><surname>Tamaoki</surname><given-names>J.</given-names></name>; <name><surname>Chiyotani</surname><given-names>A.</given-names></name>; <name><surname>Konno</surname><given-names>K.</given-names></name>
<article-title>Stimulation of opioid
mu-receptors potentiates beta adrenoceptor-mediated relaxation of
canine airway smooth muscle</article-title>. <source>J. Pharmacol. Exp.
Ther.</source>
<year>1995</year>, <volume>275</volume>, <fpage>1288</fpage>&#x02013;<lpage>1292</lpage>.<pub-id pub-id-type="pmid">8531094</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Feinberg</surname><given-names>A.
P.</given-names></name>; <name><surname>Creese</surname><given-names>I.</given-names></name>; <name><surname>Snyder</surname><given-names>S. H.</given-names></name>
<article-title>The opiate receptor: a model explaining
structure-activity relationships of opiate agonists and antagonists</article-title>. <source>Proc. Natl. Acad. Sci.</source>
<year>1976</year>, <volume>73</volume>, <fpage>4215</fpage>&#x02013;<lpage>4219</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.73.11.4215</pub-id>.<pub-id pub-id-type="pmid">186791</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Spetea</surname><given-names>M.</given-names></name>; <name><surname>Asim</surname><given-names>M. F.</given-names></name>; <name><surname>Wolber</surname><given-names>G.</given-names></name>; <name><surname>Schmidhammer</surname><given-names>H.</given-names></name>
<article-title>The &#x003bc;
opioid receptor and ligands acting at the &#x003bc; opioid receptor,
as therapeutics and potential therapeutics</article-title>. <source>Curr. Pharm. Des.</source>
<year>2014</year>, <volume>19</volume>, <fpage>7415</fpage>&#x02013;<lpage>7434</lpage>. <pub-id pub-id-type="doi">10.2174/13816128113199990362</pub-id>.</mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Stavitskaya</surname><given-names>L.</given-names></name>; <name><surname>Coop</surname><given-names>A.</given-names></name>
<article-title>Most recent developments
and modifications of 14-alkylamino and 14-alkoxy-4,5-epoxymorphinan
derivatives</article-title>. <source>Mini Rev. Med. Chem.</source>
<year>2011</year>, <volume>11</volume>, <fpage>1002</fpage>&#x02013;<lpage>1008</lpage>. <pub-id pub-id-type="doi">10.2174/138955711797247752</pub-id>.<pub-id pub-id-type="pmid">21861811</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Greedy</surname><given-names>B. M.</given-names></name>; <name><surname>Bradbury</surname><given-names>F.</given-names></name>; <name><surname>Thomas</surname><given-names>M. P.</given-names></name>; <name><surname>Grivas</surname><given-names>K.</given-names></name>; <name><surname>Cami-Kobeci</surname><given-names>G.</given-names></name>; <name><surname>Archambeau</surname><given-names>A.</given-names></name>; <name><surname>Bosse</surname><given-names>K.</given-names></name>; <name><surname>Clark</surname><given-names>M. J.</given-names></name>; <name><surname>Aceto</surname><given-names>M.</given-names></name>; <name><surname>Lewis</surname><given-names>J. W.</given-names></name>; <name><surname>Traynor</surname><given-names>J. R.</given-names></name>; <name><surname>Husbands</surname><given-names>S. M.</given-names></name>
<article-title>Orvinols with Mixed
Kappa/Mu Opioid Receptor Agonist Activity</article-title>. <source>J.
Med. Chem.</source>
<year>2013</year>, <volume>56</volume>, <fpage>3207</fpage>&#x02013;<lpage>3216</lpage>. <pub-id pub-id-type="doi">10.1021/jm301543e</pub-id>.<pub-id pub-id-type="pmid">23438330</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Ananthan</surname><given-names>S.</given-names></name>; <name><surname>Saini</surname><given-names>S. K.</given-names></name>; <name><surname>Dersch</surname><given-names>C. M.</given-names></name>; <name><surname>Xu</surname><given-names>H.</given-names></name>; <name><surname>McGlinchey</surname><given-names>N.</given-names></name>; <name><surname>Giuvelis</surname><given-names>D.</given-names></name>; <name><surname>Bilsky</surname><given-names>E. J.</given-names></name>; <name><surname>Rothman</surname><given-names>R. B.</given-names></name>
<article-title>14-Alkoxy-
and 14-Acyloxypyridomorphinans:
&#x003bc; Agonist/&#x003b4; Antagonist Opioid Analgesics with Diminished
Tolerance and Dependence Side Effects</article-title>. <source>J. Med.
Chem.</source>
<year>2012</year>, <volume>55</volume>, <fpage>8350</fpage>&#x02013;<lpage>8363</lpage>. <pub-id pub-id-type="doi">10.1021/jm300686p</pub-id>.<pub-id pub-id-type="pmid">23016952</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Greiner</surname><given-names>E.</given-names></name>; <name><surname>Spetea</surname><given-names>M.</given-names></name>; <name><surname>Krassnig</surname><given-names>R.</given-names></name>; <name><surname>Sch&#x000fc;llner</surname><given-names>F.</given-names></name>; <name><surname>Aceto</surname><given-names>M.</given-names></name>; <name><surname>Harris</surname><given-names>L. S.</given-names></name>; <name><surname>Traynor</surname><given-names>J. R.</given-names></name>; <name><surname>Woods</surname><given-names>J. H.</given-names></name>; <name><surname>Coop</surname><given-names>A.</given-names></name>; <name><surname>Schmidhammer</surname><given-names>H.</given-names></name>
<article-title>Synthesis
and Biological Evaluation
of 14-Alkoxymorphinans. 18.1N-Substituted 14-Phenylpropyloxymorphinan-6-ones
with Unanticipated Agonist Properties: Extending the Scope of Common
Structure&#x02013;Activity Relationships</article-title>. <source>J.
Med. Chem.</source>
<year>2003</year>, <volume>46</volume>, <fpage>1758</fpage>&#x02013;<lpage>1763</lpage>. <pub-id pub-id-type="doi">10.1021/jm021118o</pub-id>.<pub-id pub-id-type="pmid">12699394</pub-id></mixed-citation></ref></ref-list></back></article>